Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma

Cellular Immunology

Volumn 265, Issue 1, 2010, Pages 80-85

  Razmkhah, Mahboobeh ^a   Jaberipour, Mansooreh ^a   Hosseini, Ahmad ^a   Safaei, Akbar ^b   Khalatbari, Behzad ^b   Ghaderi, Abbas ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ASCs; Breast cancer; HGF; IGF 1; IL 8; VEGF

Indexed keywords

GELATINASE A; INTERLEUKIN 8; MESSENGER RNA; SCATTER FACTOR; SOMATOMEDIN C; VASCULOTROPIN; MMP2 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADIPOSE TISSUE; ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; BIOSYNTHESIS; BREAST TUMOR; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MESENCHYMAL STROMA CELL; MIDDLE AGED;

ADIPOSE TISSUE; ADULT; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELLS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; MESENCHYMAL STROMAL CELLS;

EID: 77956171259     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.07.006     Document Type: Article

References (31)

1. Raman D., Baugher P.J., Thu Y.M., Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007, 256:137-165.
2. Leek R.D. The prognostic role of angiogenesis in breast cancer. Anticancer Res. 2001, 21:4325-4331.
3. Mishra P.J., Glod J.W., Banerjee D. Mesenchymal stem cells: flip side of the coin. Cancer Res. 2009, 69:1255-1258.
4. Ma X.J., Dahiya S., Richardson E., Erlander M., Sgroi D.C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009, 11:R7.
5. Somiari S.B., Shriver C.D., Heckman C., Olsen C., Hu H., Jordan R., Arciero C., Russell S., Garguilo G., Hooke J., Somiari R.I. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett. 2006, 233:98-107.
6. Linderholm B.K., Hellborg H., Johansson U., Elmberger G., Skoog L., Lehtiö J., Lewensohn R. Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann. Oncol. 2009, 20:1639-1646.
7. Heidemann J., Ogawa H., Dwinell M.B., Rafiee P., Maaser C., Gockel H.R., Otterson M.F., Ota D.M., Lugering N., Domschke W., Binion D.G. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 2003, 278:8508-8515.
8. Mine S., Fujisaki T., Kawahara C., Tabata T., Iida T., Yasuda M., Yoneda T., Tanaka Y. Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Exp. Cell Res. 2003, 288:189-197.
9. Ibrahim Y.H., Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm. IGF Res. 2004, 14:261-269.
10. Kogler G., Radke T.F., Lefort A., Sensken S., Fischer J., Sorg R.V., Wernet P. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp. Hematol. 2005, 33:573-583.
11. Nakagami H., Morishita R., Maeda K., Kikuchi Y., Ogihara T., Kaneda Y. Adipose tissue derived stromal cells as a novel option for regenerative cell therapy. J. Atheroscler. Thromb. 2006, 13:77-81.
12. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002, 62:3603-3608.
13. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., Cai X., Fox J.G., Goldenring J.R., Wang T.C. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306:1568-1571.
14. Rubio D., Garcia-Castro J., Martín M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., Bernad A. Spontaneous human adult stem cell transformation. Cancer Res. 2005, 65:3035-3039.
15. Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1889, 8:98-101.
16. Son B.R., Marquez-Curtis L.A., Kucia M., Wysoczynski M., Turner A.R., Ratajczak J., Ratajczak M.Z., Janowska-Wieczorek A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006, 24:1254-1264.
17. Wong D., Korz W. Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside. Clin. Cancer Res. 2008, 14:7975-7980.
18. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nature Review 2008, 8:726-736.
19. Ries C., Egea V., Karow M., Kolb H., Jochum M., Neth P. MMP2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007, 109:4055-4063.
20. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102:3837-3844.
21. Muehlberg F.L., Song Y.H., Krohn A., Pinilla S.P., Droll L.H., Leng X., Seidensticker M., Ricke J., Altman A.M., Devarajan E., Liu W., Arlinghaus R.B., Alt E.U. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30:589-597.
22. Pinilla S., Alt E., Abdul Khalek F.J., Jotzu C., Muehlberg F., Beckmann Ch., Song Y.H. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 2009, 284:80-85.
23. Sadat S., Gehmert S., Song Y.H., Yen Y., Bai X., Gaiser S., Klein H., Alt E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
24. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
25. Soria G., Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008, 267:271-285.
26. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., Pell C.L., Johnstone B.H., Considine R.V., March K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
27. Wang M., Crisostomo P., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-1 in response to TNF by a p38 mitogen activated protein kinase dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R880-R884.
28. Rahimi N., Saulnier R., Nakamura T., Park M., Elliott B. Role of hepatocyte growth factor in breast cancer: A novel mitogenic factor secreted by adipocytes. DNA Cell. Biol. 1994, 13:1189-1197.
29. Miranville A., Heeschen C., Sengenes C., Curat C.A., Busse R., Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110:349-355.
30. Planat-Benard V., Silvestre J.S., Cousin B., André M., Nibbelink M., Tamarat R., Clergue M., Manneville C., Saillan-Barreau C., Duriez M., Tedgui A., Levy B., Pénicaud L., Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004, 109:656-663.
31. Di G.H., Lu J.S., Song C.G., Li H.C., Shen Z.Z., Shao Z.M. Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. J. Exp. Clin. Cancer. Res. 2005, 24:601-607.